diff_months: 9

31751000887000Please add your student number in the header

Download Solution Now
Added on: 2024-12-22 08:30:26
Order Code: SA Student Medical Sciences Assignment(11_22_30600_408)
Question Task Id: 477065

31751000887000Please add your student number in the header

and

select your Programme from below and delete the others

FdSc MSc Nursing pre-registration programmes

Or

MSc apprenticeship programmes

PHAM1151

Medicines Management

(insert the module occurrence number here and year of study here

e.g. MO1 2021-2022)

Summative Workbook Assessment

Max word count:

(+/- 10% 2000 for PHAM 1151 MSc students level 6)

Submission Deadline:

Word Count:

Course Leader: J C Sevenoaks

Cohort:

PTG Leader:

The workbook assignment for PHAM 1151 Level 6 Medicines management module is in two parts:

Part 1: Completion of four summative questions linked to learning outcomes 1-4.Total word count for part 1 is 2000 words.

Part 2: Completion of Essential Skills health numeracy assessment using the SafeMedicate platform with a grade of 30/30 (100%) linked to learning outcome 4. Completion of this SafeMedicate assessment needs to be evidenced as a screenshot inserted into the section marked Part 2,

Further information about this assessment will be given during the module and using the Moodle virtual learning environment and external platform of SafeMedicate.

Parts 1&2 both need to achieve as a pass grade to pass the module. A grade will be assigned to the written part 1(pass mark being 40% for level 6 work). A potential word count per question has been allocated which are weighted respectively to the marks for each question. All questions need to be answered.

Part 1: Summative Workbook

Please use this template to complete your workbook. Details of your patient are given below, and you will find the patients PSD/MAR chart in Appendix 1:

Patient scenario:

Prudence Okeke is 17-year-old who identifies as female. She has been admitted to the Medical Unit (MU) where you are on placement. Her presenting complaint is a productive cough, shortness of breath and fever for the past 2 days which developed while she was recovering from insertion of pins for a compound fracture of her right radius, while an inpatient on the Surgical Unit. Please not she is right-hand dominant. She has tested Covid 19 negative. Her primary diagnosis for this admission is Hospital Acquired Pneumonia. Sputum specimens have been sent for microscopy culture and sensitivity (MC&S) and the organism has been identified.

Her past medical history is Diabetes Mellitus type 1 which was diagnosed when she was 10 years of age. Her current medication for this is Novorapid 3 units subcutaneously via Novopen, 20 minutes before meals (or self-adjusted by carbohydrate coverage ratio adjustments). She also takes basal insulin Human Insulatard at 50 % of total daily insulin dose of 15 unit subcutaneously in the morning before breakfast. At last review her HbA1c was 46 mmol/mol. She has no other medical history of note.

She lives at home while studying for A Levels. She has 6 younger siblings and both parents do not speak English. She is a non-smoker, non-drinker and denies use of recreational drugs.

Use the provided patient history and the Patient Specific Directions (PSD) and Medicines Administration Record (MAR) (combined) to develop your answers.

Please answer all four questions in Part 1 (Q1-4). Your work must be supported with appropriate references and includes a reference list.

Part 1

Q 1: Supports Learning Outcome 1 & 2:

Understanding the whole system of medicines management including prescribing, transcribing, dispensing, storage, administering and monitoring of medicines in accordance with local and national policy. Recognise and critically reflect upon the nurses role in medication management and delegation to others, administering medication under direct supervision of a registrant in relation to legislation and national guidelines.

Q1: Provide a critical discussion of your future registrants role when identifying the legal requirements of a medication prescription prior to the administration of a drug. Support your discussion with national guidelines and policies. (Approximately 350 words, 20 marks)

Q2: Supports Learning Outcome 3: Develop a greater understanding and critically reflect upon factors which contribute to medication errors and how to deal with errors if they occur.)

Q2a: Critically describe, with reference to known evidence base and theory, the human factors which contribute to medication errors and strategies which might be employed to reduce the risk of a medication error occurring. Include discussion of learning from mistakes. (Word 325 level 6 max marks 10)

Q2b: Reviewing the attached combined PSD/MAR chart, please identify any medication error(s) which have occurred. Critically evaluate and discuss any action that needs to be taken. (Word 325 level 6 max marks 10) Q3 Supports Learning Outcome 4: Demonstrate skills and evidence-based knowledge to critically deliver safe administration and monitoring of medication via a range of delivery routes including essential health numeracy/calculation skills. With reference to the enclosed prescription chart, discuss the specific administration and monitoring considerations for this patients medication.

Q3: You are required to administer the following medication: Insulin Novorapid . Critically evaluate reflect on your role and the process involved in preparing and selection of the write equipment for this medication. The stock insulin is NovoRapid 100 units/ml ampule it is in date. Your answer should include reference to risk management, legislation, and national guidelines. (Approximately 400 words 30 marks)

Q4 supports Learning Outcome 4: Demonstrate skills and evidence-based knowledge to critically deliver safe administration and monitoring of medication via a range of delivery routes including essential health numeracy/calculation skills.

Q4 a) Regarding the intravenous fluids and IV medication prescribed, calculate the flow rate in mls per hour for the IV fluids to be delivered by a pump. Show your formular and calculated answer in full (5 marks).

b) Critically evaluate and discuss the monitoring considerations for medications via this IV route. Include reference to a range of relevant principles and guidance (Approximately 600 words 30 marks).

Reference list:

Part Two:

Evidence of completion of summative Essential Skills SafeMedicate assessment with 30/30 grade.

Please insert a screenshot here as proof of successful completion of the SafeMedicate summative Essential Skills numeracy assessment. This screenshot must clearly show your name and student ID and grade achieved.

Example of a screen shot of your safe medicate results please delete the example below and replace with your own evidence of successful completion.

To take a screen shot you need to access your results in the assessment feedback, hover your mouse over this top section and press prt scr (which is usually at the top right of your computer).

You need to have your workbook word document open and right click past the document in this section and save the document as evidence of passing this element of the workbook.

During the module you will be given formative practice using Safe Medicate essential skills questions for this section of the workbook and then a set period of time for you to achieve the summative pass evidence as seen above. You will be given instructions about when you can take this assessment to be included here by your module team.

By placing a tick () in the box below you are indicating the safe medicate assessment was undertaken by yourself and is no one elses work

Date competed:

17348204445I confirm this is my own work

Please remember to save this section of the workbook and ensure it is the one you want marked you do not need to submit the MAR below:

Appendix 1: Patient Specific Direction (PSD)/Medication Administration Record (MAR) chart

3956792-10566100Greenwich University Hospitals

Surname: OKEKE

Forename(s): Prudence

Date of birth: 7.7.2004 (currently 17years old)

Hospital Number: 777222

Height (m): not recorded on admission guestimate 156 CM

Weight (kg): 55 Kg

Ward: Surgical ward P transferred to Medical Ward Q Consultant: Dr Pepper Senior

Date of admission: 1.1.22 transferred on 3.1.22 Time of admission: 09.00

Number of prescription records

Chart 1 2 3 of 1 2 3

Number of prescription records

Chart 1 2 3 of 1 2 3

ALERTS: Allergies/sensitivities/adverse reaction

Medicine(s) or foods Effect(s)

Shellfish Swelling of the tongue

Penicillin Urticarial rash and itch

IF NO KNOWN ALLERGIES TICK BOX 260352032100 Signature: Dr pepper Bleep Number: 123 Date: 1.1.22

Allergy status MUST be completed and SIGNED by a prescriber/pharmacist/nurse BEFORE any medicines are administered.

Medication risk factors

Pregnancy Renal Impairment Impaired oral access Diabetes

Other high-risk conditions specify

Patient self-medicating

Medicine non-administration/self-administration:

If a dose is omitted for any reason, the nurse should enter the relevant code on the administration record, sign, and date the entry.

1.Medicine unavailable 2.Patient off ward

3.Self-administration 4.Unable to administer

5.Stat dose given 6.Prescription incorrect/unclear

7.Patient refused 8.Nil by mouth (on doctors instruction only)

9.Low pulse and/or low blood pressure 10.Other state in nursing notes including action taken

ONCE ONLY MEDICINES, PREMEDICATION, ANTIBIOTIC PROPHYLAXIS AND PATIENT GROUP DIRECTIONS

Date Drug Dose Route Instructions Time required Prescribers signature, print name

& bleep number Time given Signature given Pharmacy check

1.1.22

1.1.22 Oral morphine solution 10 mg oral For pain 09.00 Dr Will Sleep

321 09.05 Nurse

K. AJA

465455217805000

HOSPITAL MEDICATION PRESCRIPTION AND ADMINISTRATION RECORD

Surname: OKEKE

Forename(s): Prudence

Date of birth: 7.7.2004

Hospital Number: 777222 Height (m):

Weight (kg): 55kg

Ward: MU Consultant:

Date of admission: Time of admission:

PRESCRIBED OXYGEN

For most chronic conditions, oxygen should be prescribed to achieve a target saturation of 94-98% (or 88-92% for those at risk of hypercapnic respiratory failure i.e. CO2 retainers).

Is the patient a known CO2 retainer?No

Continuous oxygen therapy

Target O2 saturation 94-98%

When required oxygen therapy

Target O2 saturation 88-92%

Other saturation range: Saturation not indicated e.g. end-of-life care (state reason) Check and record flow rate (FR) and device (D) at each medicine round or other times specified.

Starting device and flow rate:

N and 2 L/min Start date: 3.1.22

Today Date Time FR/D

3.1.22 09.00 Checked 2 L/min via N

Prescribers signature: Dr R Pepper Stop date: Print name: Dr R Pepper Pharmacy check: Codes for starting device and modes of delivery

Air not requiring oxygen or weaning or PRN oxygen A Humidified oxygen at 28% (add% for other flow rate) H28

Nasal cannulaeN Reservoir mask RM

Simple mask M Tracheostomy mask TM

Venturi 24 V24 Venturi 35 V35

Venturi 28 V28 Venturi 40 V40

Venturi 60 V60 Patient on CPAP system CP

Patient on NIV system NIV Other device (specify) Venous Thromboembolism Risk Assessment

Does this patient need thromboprophylaxis? Y/N Signature Date

N Dr R Pepper today

If yes, please prescribe appropriate thromboprophylaxis on prescription chart.

If contraindicated please state reason:

NB: reassess risk of bleeding and venous thromboembolism within 24 hours and if clinical situation changes

HOSPITAL MEDICATION PRESCRIPTION AND ADMINISTRATION RECORD

Surname: OKEKE

Forename(s): Prudence

Date of birth: 7.7.2004

Hospital Number: 777222

Height (m): not recorded on admission 156Cm

Weight (kg): 55kg

Ward: transferred into medical ward Consultant: Dr Pepper senior

Date of admission: 1.1.22 surgical unit transferred on 3.1.22 Time of admission: 09.00

ANTIMICROBIALS

Review IV after 24-48 hours Review oral after 5-7 days

1.Drug Tazocin Date and signature of nurse administering medications and code if not administered.

Date Dose Frequency Route Duration Date/Time/sig Date/Time/sig:

Date/time/sig:

Date/time/sig

3.1.22 4.5 g

diluted in 50 mls 0.9% NaCl Every 8 hours IV infused over 30 mins 5 days 3.1.22

08.00

Tobi Xin Start date 3.1.22 Indication/ Organism For Hospital acquired pneumonia

Finish date 8.1.22 Cultures sent? Yes Prescribers signature and bleep Dr R Pepper bleep 123 Print name Dr R Pepper Pharmacy

Check 2.Drug Gentamicin Date and signature of nurse administering medications and code if not administered.

Date Dose Frequency Route Duration Date/Time/ Sig Date/time/sig Date/time/sig

Date/time sig

Today 385 mg

diluted in 50 mls 0.9% NaCl Once daily IV

infused over 60 mins 3 days 3.1.22

09.00

PEvansStart date 3.1.22 Indication/ Organism For Hospital acquired pneumonia per dose 7 mg/kg Finish date 6.1.22 Cultures sent? Yes Prescribers signature and bleep Dr R Pepper bleep 123 Print name Dr R pepper Pharmacy

Check HOSPITAL MEDICATION PRESCRIPTION AND ADMINISTRATION RECORD

Surname: OKEKE

Forename(s): Prudence

Date of birth: 7.7.2004

Hospital Number: 777222 Height (m):

Weight (kg): 55 kg

Ward: Medical ward Consultant: Dr R Pepper

Date of admission: 3.1.22 Time of admission:

REGULAR MEDICINES

VTE PRESCRIPTION ONLY. Preparation:

Date and signature of nurse administering medications and code if not administered.

Date Dose Frequency Route Duration Time Date: Date: Date: Date:

Start date Instructions/indication

Finish Date Pharmacy

Check Prescribers signature and bleep Print name Drug Insulin Novorapid Date and signature of nurse administering medications and code if not administered.

Date Dose Frequency Route Duration Time Date: signature Time Date: signature 1.1.22 3 units 20 mins before meals S/c Ongoing 13.00 1.1.22

K. AJA 18.00 1.1.22 K. K. AJA AJAStart date 1.1.22 Instructions/indication Check peripheral Blood glucose levels via figure prick before meals give if blood glucose is between 4-7 mmols refer to Dr if above 7 mmols/l or needs adjusting for Carbohydrate coverage

Withhold and consult Dr if below 4 mmols/l administer glyco stop as per hypoglycaemia policy

Finish Date Pharmacy

Check yes Prescribers signature and bleep Dr R Pepper bleep 123 Print name Dr R Pepper

Drug Insulin human (Insulatard) 100 IU/ml Date and signature of nurse administering medications and code if not administered.

Date Dose Frequency Route Duration Time Date: signature time: Date: signature 1.1.22 15 unit Once a day S/c ongoing 07.00 2.1.22

K. AJA 07.00 3.1.22 A JA Start date 1.2.22 Instructions/indication

Finish Date Pharmacy

Check yes Prescribers signature and bleep Dr R Pepper bleep 123 Print name Dr R Pepper

HOSPITAL MEDICATION PRESCRIPTION AND ADMINISTRATION RECORD

Surname: Pepper

Forename(s): Prudence

Date of birth: 7.7.2004

Hospital Number: 777222 Height (m): 156 cm

Weight (kg): 55 kg

Ward: MUA Consultant: Dr Pepper Senior

Date of admission: 1.1.22 Time of admission: 09.00

AS REQUIRED MEDICINES

Drug Paracetamol Date and signature of nurse administering medications and code if not administered.

Date Dose Frequency Route Duration Time date Signature Time date Signature 1.1.22 1000mg 4-6 hours max 4 g in 24 hours PO 3 days 1.1.22

22.00 Gale.Plage2.1.22

07.00 Gale.PlageStart date 1.1.22 Instructions/indication for distress /discomfort with pain or fever

2.1.22

13.00 P Evans 2.1.22

21.00 Gale.PlageFinish Date 3.1.22

06.00 Gale.PlagePharmacy

Check Prescribers signature and bleep Dr R Pepper bleep 123 Print name Drug Ibuprofen Date and signature of nurse administering medications and code if not administered.

Date Dose Frequency Route Duration Time Date: signature Date: signature 1.2.22 300mg-400 mg 6-8 hourly max 2400 mg in 24 hours Po 2.2.22 18.00 P Evans Start date 1.2.22 Instructions/indication

With food Finish Date Prescribers signature and bleep Dr R Pepper bleep 123 Print name Dr R Pepper

HOSPITAL MEDICATION PRESCRIPTION AND ADMINISTRATION RECORD

Surname: OKEKE

Forename(s): Prudence

Date of birth: 7.7.2004

Hospital Number: 777222 Height (m):

Weight (kg): 55kg

Ward: Medical ward Consultant: Dr R Pepper

Date of admission: 3.1.22 Time of admission: 09.00

INFUSIONS

Bolus IM injections should be prescribed on the standard section of the drug chart. If no additive is to be used, enter nil in the drug added column.

Date INFUSION FLUID Duration or rate Prescribers signature Given by Checked by Start time Stop time Vol. given (ml)

Name/strength Volume (ml) Route (IV/SC) 3.1.22 0.9% NaCl with 10 mmols of KCl500 IV 8 hourDr R Pepper bleep 123

  • Uploaded By : Pooja Dhaka
  • Posted on : December 22nd, 2024
  • Downloads : 0
  • Views : 129

Download Solution Now

Can't find what you're looking for?

Whatsapp Tap to ChatGet instant assistance

Choose a Plan

Premium

80 USD
  • All in Gold, plus:
  • 30-minute live one-to-one session with an expert
    • Understanding Marking Rubric
    • Understanding task requirements
    • Structuring & Formatting
    • Referencing & Citing
Most
Popular

Gold

30 50 USD
  • Get the Full Used Solution
    (Solution is already submitted and 100% plagiarised.
    Can only be used for reference purposes)
Save 33%

Silver

20 USD
  • Journals
  • Peer-Reviewed Articles
  • Books
  • Various other Data Sources – ProQuest, Informit, Scopus, Academic Search Complete, EBSCO, Exerpta Medica Database, and more